您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
PRO / Antibodies

In Vivo Star Anti-Mouse CD16/CD32 Antibody

In Vivo Star Anti-Mouse CD16/CD32 Antibody

英诺赛图(InnoCyto)的 In Vivo Star Anti-Mouse CD16/CD32 Antibody(克隆 2.4G2-m2aSL) 为鼠源 IgG2a LALAPG Kappa 抗体,靶向 CD16/32(别名 Fcγ R III/II 等)。提供 1 mg、5 mg、25 mg 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。

生物试剂 供应商 上海英诺赛图 ↗ 型号 511101 更新 2026-11-12
参考价格区间
¥1,085
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 In Vivo Star Anti-Mouse CD16/CD32 Antibody(克隆 2.4G2-m2aSL) 为鼠源 IgG2a LALAPG Kappa 抗体,靶向 CD16/32(别名 Fcγ R III/II 等)。提供 1 mg、5 mg、25 mg 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

510901 | 1 mg | ¥1,085

510902 | 5 mg | ¥2,712

510903 | 25 mg | ¥7,458

511001 | 1 mg | ¥1,085

511002 | 5 mg | ¥2,712

511003 | 25 mg | ¥7,458

511101 | 1 mg | ¥1,085

511102 | 5 mg | ¥2,712

511103 | 25 mg | ¥7,458

511201 | 1 mg | ¥6,102

511202 | 5 mg | ¥14,916

511203 | 25 mg | ¥40,002

511301 | 1 mg | ¥1,085

511302 | 5 mg | ¥2,712

511303 | 25 mg | ¥7,458

511401 | 1 mg | ¥1,085

511402 | 5 mg | ¥2,712

511403 | 25 mg | ¥7,458

Product Details

Application|ELISA, WB, Flow cytometry, IHC, ICC, animal model study

Product Description|In vivo Grade Recombinant Anti-mouse CD16/CD32 Monoclonal Antibody

Regulatory Status|RUO

Endotoxin

Storage Conditions|4ºC

Recommended Usage|This product is suitable for in vivo animal use. Optimal amounts need to be determined empirically for each experiment.

See All Formats|Clone 2.4G2-m2aSL

Background Information

CD16 (FcγRIII) and CD32 (FcγRII) are receptors for the Fc region of immunoglobulin G (IgG) and are key mediators of antibody-dependent immune responses. They are expressed on a variety of immune cells, including natural killer (NK) cells, monocytes, macrophages, neutrophils, dendritic cells, and B cells. By linking antibody recognition to cellular effector functions, CD16 and CD32 serve as critical bridges between humoral immunity and innate immune mechanisms.

Structurally, both CD16 and CD32 are members of the immunoglobulin superfamily but differ in affinity, signaling capacity, and cellular distribution. CD16 exists in two main forms: CD16a (FcγRIIIa), a transmembrane receptor expressed on NK cells and myeloid cells that associates with signaling adaptor chains containing immunoreceptor tyrosine-based activation motifs (ITAMs), and CD16b (FcγRIIIb), a glycosylphosphatidylinositol (GPI)-anchored receptor expressed primarily on neutrophils. CD32 includes several isoforms, most notably CD32a (FcγRIIa) and CD32b (FcγRIIb), which are transmembrane receptors with distinct cytoplasmic signaling motifs.

The ligands for CD16 and CD32 are IgG antibodies bound to antigen, forming immune complexes. CD16 primarily binds IgG1 and IgG3 and is a major mediator of antibody-dependent cellular cytotoxicity (ADCC), particularly by NK cells. CD32a transmits activating signals via an intrinsic ITAM, promoting phagocytosis, cytokine release, and inflammatory responses. In contrast, CD32b contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) in its cytoplasmic tail and functions as a negative regulator, dampening B cell receptor and Fc receptor signaling to maintain immune balance.

Altered expression or function of CD16 and CD32 is implicated in a range of diseases. In autoimmune disorders such as systemic lupus erythematosus and rheumatoid arthritis, dysregulated Fcγ receptor signaling contributes to immune complex–mediated inflammation and tissue damage. In infectious diseases, these receptors are essential for efficient clearance of antibody-opsonized pathogens. Genetic polymorphisms in CD16 and CD32 influence IgG binding affinity and are associated with variability in susceptibility to disease and responses to antibody-based therapies.

Therapeutically, CD16 and CD32 are central to the mechanism of action of many monoclonal antibody drugs. Engagement of CD16 on NK cells is critical for ADCC-mediated tumor cell killing, making it a key determinant of antibody efficacy in cancer therapy. Engineering antibodies to enhance Fcγ receptor binding is an active area of drug development. Conversely, targeting inhibitory CD32b signaling is being explored to modulate immune responses in autoimmunity and to improve vaccine efficacy. Together, CD16 and CD32 represent pivotal regulators of antibody-driven immunity with broad clinical relevance.

Data Sheets

Cat # Size Price Quantity 5111011 mg Add to Cart5111025 mg Add to Cart51110325 mg Add to Cart

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格1 mg
Clone2.4G2-m2aSL
Host SpeciesCHO cells
ReactivityMouse
FormatLiquid
Target NameCD16/32, Fcγ R III/II, Ly-17
Product DescriptionIn vivo Grade Recombinant Anti-mouse CD16/CD32 Monoclonal Antibody
IsotypeMouse IgG2a LALAPG Kappa
Antibody TypeRecombinant
Regulatory StatusRUO
Purity>95% by reducing SDS-PAGE
Storage Conditions4ºC
GradeIn vivo
Recommended UsageThis product is suitable for in vivo animal use. Optimal amounts need to be determined empirically for each experiment.
RRIDAB_3739385
目录价¥1,085

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). In Vivo Star Anti-Mouse CD16/CD32 Antibody(511101)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-cd16-cd32-antibody-511101.html.
TeleVM. (2026, November 12). In Vivo Star Anti-Mouse CD16/CD32 Antibody(511101). 产品目录. https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-cd16-cd32-antibody-511101.html
@misc{biocsp_item_in_vivo_star_anti_mouse_cd16_cd32_antibody_511101,
  title        = {In Vivo Star Anti-Mouse CD16/CD32 Antibody(511101)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-cd16-cd32-antibody-511101.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

In Vivo Star Anti-Mouse CD16/CD32 Antibody

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。